Predictive Oncology Inc.
POAI
$0.96
-$0.03-3.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.60% | -- | -- | 24.59% | -21.39% |
| Total Depreciation and Amortization | -71.04% | -- | -- | 7.67% | -70.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,864.29% | -- | -- | 329.62% | -123.68% |
| Change in Net Operating Assets | 310.49% | -- | -- | -145.62% | 303.89% |
| Cash from Operations | 64.80% | -- | -- | 5.79% | -10.82% |
| Capital Expenditure | -- | -- | -- | -116.67% | -119.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -116.67% | -141.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 66.19% | -2.37% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,376.66% | -- | -- | 3,088.52% | -0.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 201.02% | -- | -- | 103.81% | -10.83% |